238 related articles for article (PubMed ID: 35387473)
21. Subacute thyroiditis following COVID-19 vaccination: Case presentation.
Tomic AZ; Zafirovic SS; Gluvic ZM; Samardzic VS; Macvanin MT; Radunovic ML; Isenovic ER
Antivir Ther; 2023 Oct; 28(5):13596535231208831. PubMed ID: 37861754
[No Abstract] [Full Text] [Related]
22. Strong Correlation between HLA and Clinical Course of Subacute Thyroiditis-A Report of the Three Siblings.
Stasiak M; Lewiński A
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33138008
[TBL] [Abstract][Full Text] [Related]
23. Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review.
Viola N; Brancatella A; Sgrò D; Santini F; Latrofa F
Endocrine; 2023 Mar; 79(3):448-454. PubMed ID: 36394704
[TBL] [Abstract][Full Text] [Related]
24. Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series.
Brancatella A; Ricci D; Cappellani D; Viola N; Sgrò D; Santini F; Latrofa F
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32780854
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
26. SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype.
Silvestri Y; Clemente F; Moschetti G; Maioli S; Carelli E; Espadas de Arias A; Torelli R; Longhi E; De Feo T; Crosti M; Sarnicola ML; Salvi M; Mantovani G; Arosio M; Bombaci M; Pesce E; Grifantini R; Abrignani S; Geginat J; Muller I
Clin Immunol; 2023 Sep; 254():109684. PubMed ID: 37451415
[TBL] [Abstract][Full Text] [Related]
27. The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine.
Popescu M; Ghemigian A; Vasile CM; Costache A; Carsote M; Ghenea AE
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454008
[TBL] [Abstract][Full Text] [Related]
28. Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine.
Ziaka M; Exadaktylos A
Virol J; 2023 Jun; 20(1):132. PubMed ID: 37344878
[TBL] [Abstract][Full Text] [Related]
29. Successful Management of Subacute Thyroiditis Following SARS-CoV-2 Infection.
Sato D; Nishiguchi S; Tanaka E
Intern Med; 2021 Nov; 60(22):3573-3576. PubMed ID: 34511569
[TBL] [Abstract][Full Text] [Related]
30. A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients.
Poulton K; Wright P; Hughes P; Savic S; Welberry Smith M; Guiver M; Morton M; van Dellen D; Tholouli E; Wynn R; Clark B
Int J Immunogenet; 2020 Aug; 47(4):324-328. PubMed ID: 32623831
[TBL] [Abstract][Full Text] [Related]
31. Subacute Thyroiditis After Sars-COV-2 Infection.
Brancatella A; Ricci D; Viola N; Sgrò D; Santini F; Latrofa F
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32436948
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the diagnostic features and clinical course of COVID-19 vaccine-associated subacute thyroiditis.
Bostan H; Kayihan S; Calapkulu M; Hepsen S; Gul U; Ozturk Unsal I; Kizilgul M; Sencar ME; Cakal E; Ucan B
Hormones (Athens); 2022 Sep; 21(3):447-455. PubMed ID: 35711078
[TBL] [Abstract][Full Text] [Related]
33. Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.
Caironi V; Pitoia F; Trimboli P
Front Endocrinol (Lausanne); 2022; 13():900964. PubMed ID: 35813627
[TBL] [Abstract][Full Text] [Related]
34. Subacute thyroiditis associated with thyrotoxic periodic paralysis after COVID-19 vaccination: a case report.
Murashita M; Wada N; Baba S; Sugawara H; Miyoshi A; Obara S
Endocrinol Diabetes Metab Case Rep; 2022 May; 2022():. PubMed ID: 35578985
[TBL] [Abstract][Full Text] [Related]
35. Association between the HLA genotype and the severity of COVID-19 infection among South Asians.
Naemi FMA; Al-Adwani S; Al-Khatabi H; Al-Nazawi A
J Med Virol; 2021 Jul; 93(7):4430-4437. PubMed ID: 33830530
[TBL] [Abstract][Full Text] [Related]
36. A Case Report of Concurrent Graves' Disease and Subacute Thyroiditis Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome (ASIA).
Taşkaldıran I; Altay FP; Bozkuş Y; İyidir ÖT; Nar A; Tütüncü NB
Endocr Metab Immune Disord Drug Targets; 2023; 23(2):242-246. PubMed ID: 35726807
[TBL] [Abstract][Full Text] [Related]
37. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
Caron P
Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
[TBL] [Abstract][Full Text] [Related]
39. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
Front Public Health; 2021; 9():778964. PubMed ID: 34888290
[No Abstract] [Full Text] [Related]
40. Impact of the COVID-19 pandemic on the incidence, seasonal distribution, and characteristics of subacute thyroiditis.
Bostan H; Sencar ME; Calapkulu M; Kayihan S; Hepsen S; Cimsir A; Gul U; Ozturk Unsal I; Ozcelik O; Kizilgul M; Ucan B; Cakal E
Endocrine; 2023 Feb; 79(2):323-330. PubMed ID: 36129593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
